Back

Insights / Oct 18, 2019

QEII observational study underway to revolutionize obstructive sleep apnea treatment

Dr Hanafi is describes…

<img class="img-responsive" src="https://novaresp.ai/wp-content/themes/NovaResp/img/logo.svg" alt="NovaResp">

<img src="https://novaresp.ai/wp-content/themes/NovaResp/img/social/t.svg" loading="lazy" alt="twitter">

<img src="https://novaresp.ai/wp-content/themes/NovaResp/img/social/in.svg" loading="lazy" alt="linkedin">

<img src="https://novaresp.ai/wp-content/themes/NovaResp/img/social/f.svg" loading="lazy" alt="facebook">

cMAP™ is an investigational technology still under development and not yet commercially available.

CPAP Brands displayed are shown for illustration purposes only, and do not associate with nor endorse the products and services of NovaResp.

© 2024 NovaResp. All Rights Reserved.

Website Policy